Back to top

Basilea lifts 2026 profit outlook as anti-infectives pipeline and Cresemba sales power H1 results

The latest update is out from Basilea Pharmaceutica ( ($CH:BSLN) ). Basilea Pharmaceutica reported a strong first half of 2026, with total revenue ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Basilea Pharmaceutica AG (BPMUF)